China SXT Pharmaceuticals... (SXTC)

AI Score

Unlock

2.06

1.04 (101.96%)

At close: Apr 22, 2025, 3:59 PM

China SXT Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q1 2018	Q4 2017
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Jun 30, 2017	Mar 31, 2017
Cash & Equivalents	12.07M	12.07M	11.47M	11.47M	17.37M	17.37M	2.98M	2.98M	15.52M	15.52M	31.32K	31.32K	13.33M	13.33M	10.35M	10.35M	7.29M	7.29M	8.25M	8.25M	9.13M	9.13M	217.01K	217.01K	560.25K	24.23K	-65.57K	65.57K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	131.14K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-530.37K	n/a	-112.85K	n/a	3.5M	3.5M	-13.5K	n/a	n/a	n/a	-6.17K	n/a	n/a	n/a
Other Long-Term Assets	8.31M	8.31M	-1	n/a	8.74M	8.74M	8.43M	8.43M	9.46M	9.46M	9.31M	9.31M	9.16M	9.48M	530.37K	23.37K	112.85K	112.84K	n/a	12.68K	13.5K	13.5K	n/a	52.15K	6.17K	n/a	-65.57K	n/a
Receivables	1.35M	1.31M	1.31M	1.31M	1.58M	1.34M	3.32M	3.32M	3.37M	3.37M	10.06M	3.88M	7.77M	4.51M	9.53M	5.58M	10.65M	3.84M	7.9M	4.57M	4.18M	4.26M	3.98M	3.98M	3.91M	5.87M	n/a	3.21M
Inventory	794.86K	809.76K	581.32K	581.32K	531.25K	577.56K	628.19K	686.31K	1.02M	1.07M	837.45K	1.37M	859.7K	1.38M	867.28K	1.35M	892.77K	1.05M	846.28K	1.13M	1.01M	1.33M	1.07M	1.37M	1.27M	1.45M	n/a	1.02M
Other Current Assets	38.48K	38.48K	49.88K	137.98K	-46.3K	230.64K	583.15K	5.37M	2.58M	2.49M	6.38M	6.38M	4.01M	4.01M	4.78M	4.78M	7.64M	7.47M	3.6M	3.6M	1.27M	868.42K	228.71K	907.48K	134.73K	176.59K	n/a	615.15K
Total Current Assets	14.23M	14.23M	13.5M	13.5M	19.52M	19.52M	12.36M	12.36M	22.45M	22.45M	11.66M	11.66M	23.23M	23.23M	22.06M	22.06M	19.64M	19.64M	17.54M	17.54M	15.59M	15.59M	6.55M	6.48M	6.1M	7.52M	65.57K	4.91M
Property-Plant & Equipment	564.69K	564.69K	1.07M	1.07M	1.27M	1.27M	1.36M	1.36M	1.59M	1.59M	1.65M	1.65M	1.79M	1.79M	1.91M	1.91M	1.9M	1.9M	1.94M	1.94M	1.81M	1.81M	1.35M	1.35M	1.49M	555.08K	n/a	485.29K
Goodwill & Intangibles	19.1K	19.1K	22.51K	22.51K	27.87K	27.87K	30.72K	30.72K	38.76K	38.76K	42.35K	42.35K	45.8K	45.8K	48.2K	48.2K	50.05K	50.05K	53.39K	53.39K	61.1K	61.1K	52.08K	52.08K	60.67K	48K	n/a	41K
Total Long-Term Assets	8.89M	8.89M	1.09M	1.09M	10.03M	10.03M	9.82M	9.82M	11.09M	11.09M	11.01M	11.01M	11.31M	11.31M	1.98M	1.98M	2.07M	2.07M	5.5M	5.5M	1.88M	1.88M	1.4M	1.45M	1.56M	603.08K	-65.57K	526.3K
Total Assets	23.13M	23.13M	14.59M	14.59M	29.55M	29.55M	22.18M	22.18M	33.55M	33.55M	22.67M	22.67M	34.55M	34.55M	24.04M	24.04M	21.7M	21.7M	23.05M	23.05M	17.47M	17.47M	7.95M	7.93M	7.66M	8.12M	n/a	5.43M
Account Payables	1.28M	1.28M	1.32M	1.32M	1.38M	1.38M	1.56M	1.56M	1.48M	1.48M	1.49M	1.49M	1.46M	1.46M	1.36M	1.36M	1.94M	1.94M	1.96M	1.96M	1.69M	1.69M	2M	2M	2.41M	2.9M	n/a	1.26M
Deferred Revenue	1.05M	1.65M	190.19K	n/a	165.53K	n/a	65.1K	n/a	77.37K	n/a	218.64K	n/a	257.45K	n/a	217.41K	n/a	298.04K	n/a	120.58K	n/a	57.55K	n/a	117.99K	n/a	292.95K	n/a	n/a	n/a
Short-Term Debt	2.29M	3.34M	2.78M	3.2M	3.33M	8.54M	1.21M	1.21M	2.05M	10.74M	24.04K	2.14M	37.12K	12.19M	45.76K	45.76K	6.69M	6.69M	5.04M	6.88M	261.15K	2.74M	192.61K	380.34K	385.12K	304.21K	n/a	302.17K
Other Current Liabilities	2.63M	2.63M	2.97M	2.54M	7.99M	2.79M	2.95M	2.58M	122.77K	2.89M	5.96M	3.36M	1.29M	3.42M	3.58M	3.04M	401.32K	2.83M	3.06M	1.23M	242.99K	1.32M	1.51M	1.41M	1.47M	1.92M	n/a	1.67M
Total Current Liabilities	8.9M	8.9M	9.2M	9.2M	14.5M	14.5M	7.29M	7.29M	17.12M	17.12M	8.88M	8.88M	18.58M	18.58M	5.51M	5.51M	12.26M	12.26M	10.76M	10.76M	6.32M	6.32M	3.99M	3.97M	4.37M	5.12M	n/a	3.58M
Long-Term Debt	117.13K	117.13K	106.58K	106.58K	117.86K	117.86K	n/a	n/a	n/a	n/a	n/a	n/a	6.29K	6.29K	15.21K	15.21K	36.51K	36.51K	873.28K	873.28K	41.71K	41.71K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	294.67K	294.67K	311.51K	311.51K	365.82K	365.82K	2.83M	n/a	3.61M	n/a	n/a	n/a	6.29K	6.29K	15.21K	15.21K	36.51K	36.51K	873.28K	873.28K	41.71K	41.71K	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	9.2M	9.2M	9.51M	9.51M	14.86M	14.86M	7.29M	7.29M	17.12M	17.12M	8.88M	8.88M	18.59M	18.59M	5.52M	5.52M	12.3M	12.3M	11.64M	11.64M	6.36M	6.36M	3.99M	3.97M	4.37M	5.12M	n/a	3.58M
Total Debt	2.65M	3.46M	3.15M	3.52M	3.76M	8.9M	1.21M	1.21M	2.05M	10.74M	24.04K	2.14M	43.41K	12.19M	60.97K	60.97K	6.72M	6.72M	5.92M	7.75M	261.15K	2.79M	192.61K	380.34K	385.12K	304.21K	n/a	302.17K
Common Stock	4.35M	4.35M	1.45M	1.45M	913.78K	913.78K	288.08K	288.08K	162.47K	162.47K	67.44K	67.44K	62.06K	62.06K	62.06K	62.06K	34.67K	34.67K	23.22K	23.22K	22.71K	22.71K	20K	20K	20K	20K	n/a	20K
Retained Earnings	-24.71M	-24.71M	-31.31M	-31.31M	-21.61M	-21.61M	-17.18M	-17.18M	-15.69M	-15.69M	-13.04M	-13.04M	-9.95M	-9.95M	-5.82M	-5.82M	-7.2M	-7.2M	735.8K	735.8K	3.08M	3.08M	2.54M	2.54M	1.54M	1.36M	n/a	357.06K
Comprehensive Income	-1.03M	-1.03M	-1.02M	-1.02M	-197.57K	-197.57K	-779.39K	-779.39K	956.14K	956.14K	758.82K	758.82K	527.79K	527.78K	48.12K	48.12K	-590.66K	-590.66K	-756.92K	-756.92K	50.4K	50.39K	-63.7K	-54.23K	257.37K	307.16K	1.85M	11.82K
Shareholders Equity	13.93M	13.93M	5.08M	5.08M	14.69M	14.69M	14.89M	14.89M	16.42M	16.42M	13.79M	13.79M	15.96M	15.96M	18.52M	18.52M	9.4M	9.4M	11.41M	11.41M	11.11M	11.11M	3.96M	3.97M	3.29M	3M	1.85M	1.85M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-530.37K	n/a	-112.85K	n/a	3.5M	3.5M	-13.5K	n/a	n/a	n/a	-6.17K	n/a	131.14K	n/a